Brazil: untapped market for big pharma manufacturing
Pharmaceutical Technology
AUGUST 30, 2022
Brazilian pharma production sites are involved in Covid-19 vaccine and therapy manufacture. Oswaldo Cruz Foundation will package the drug in its facility in Rio de Janeiro before supplying it to the Brazilian public health system; the company is also involved in clinical trials for the drug’s possible use as Covid-19 prophylaxis.
Let's personalize your content